Le Lézard
Classified in: Health
Subjects: PET, ANW

Mercy For Animals Applauds Progress As Nestlé USA Announces Critical Improvements To Animal Welfare Policy


LOS ANGELES, Oct. 12, 2017 /PRNewswire/ -- Nestlé, the world's largest food and beverage company, pledged today to end many of the worst abuses endured by millions of chickens raised and slaughtered in its U.S. supply chain.

Mercy For Animals logo

Nestlé USA's animal welfare policy will meet standards set by Global Animal Partnership (GAP), an international animal welfare rating program, which include the following:

The new policy, which follows discussions with Mercy For Animals, will be implemented in full by 2024. With this announcement, Nestlé USA joins other major food manufacturers that have issued similar commitments, including General Mills, Unilever, and Campbell, as well as leading chain restaurants, including Subway, Burger King, Chipotle, Quiznos, and Panera Bread.  

"Nestlé USA has taken a big step toward ending many of the worst forms of animal abuse in the factory farming industry," said Brent Cox, vice president of corporate outreach with Mercy For Animals. "This new policy will significantly reduce suffering for millions of animals each year. The days are numbered for the factory farming industry's cruelest practices. It is time for companies like Wendy's to stop dragging their feet and follow Nestle USA's lead in implementing much-needed animal welfare improvements for their supply chains."

The best way for individual consumers to protect chickens and other farmed animals from cruelty is simply to leave them off their plates. To learn more about Mercy For Animals and its efforts to help farmed animals, visit MercyForAnimals.org.

 

SOURCE Mercy For Animals


These press releases may also interest you

at 08:05
Gilead Sciences, Inc. today announced the U.S. Food and Drug Administration (FDA) approved an updated label with additional data reinforcing the safety and efficacy profile of Biktarvy® (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide...

at 08:05
Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (MDNAF: OTCQB), a clinical-stage immunotherapy company focused on the development of engineered cytokines, today announced a CA$20 million investment by RA Capital Management, a multi-stage...

at 08:02
Sobi® today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has issued a positive opinion recommending approval of efanesoctocog alfa, for the treatment and prevention of bleeds and perioperative...

at 08:00
Citius Pharmaceuticals Inc. ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products, today announced that it has entered into definitive...

at 08:00
Florida Cancer Specialists & Research Institute, LLC (FCS) President & Managing Physician Lucio N. Gordan, MD will serve as a panelist at the 2024 Oncology Fellows & Faculty Forum in Miami, sponsored by PrecisCa and the Community Oncology Alliance...

at 08:00
Renibus Therapeutics® ("Renibus"), a clinical-stage biopharmaceutical company focusing on the prevention and treatment of cardio, renal and metabolic diseases, today announced its participation at two prestigious medical conferences: the American...



News published on and distributed by: